News Sentiment

IDXX sentiment intelligence

IDEXX Laboratories Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 563.57 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+1.0% over one week, +0.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Idexx Laboratories (IDXX) Shows Promising Growth Potential

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 1.0% Price digesting
Trend fit Trend inactive 0.5% over four weeks
Fair value 6.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 26
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
simplywall.st 7
Ad-hoc-news.de 6
TIKR.com 4
TradingView 4
Quiver Quantitative 3
MarketWatch 3
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 16
Analyst action 5
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 49
MarketWatch Direct company coverage

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock decreased by 4.17% on Tuesday, closing at $540.68. This performance was in contrast to the broader market, which saw the S&P 500 Index and the Dow Jones Industrial Average both rise. The decline ended a three-day winning streak for IDEXX Labor

Tone
Negative 29/100
Event
Market update
Published
14 Jul 2026 16:51
Source
MarketWatch
The Globe and Mail Direct company coverage

Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H

This article identifies three AI-led medical device companies, Intuitive Surgical Inc. (ISRG), IDEXX Laboratories Inc. (IDXX), and Alcon Inc. (ALC), that underperformed in the first half of 2026 but are expected to gain momentum in the second half. Each company leverages AI in it

Tone
Positive 68/100
Event
Market update
Published
14 Jul 2026 12:48
Source
The Globe and Mail
Quiver Quantitative Direct company coverage

Donald Trump - IDEXX LABS UNSOLICITED Trump Trade on Mar. 23, 2026

The article reports that Donald Trump made an unsolicited purchase of IDEXX LABS (IDXX) stock on March 23, 2026, with a value between $15,001 and $50,000. It also notes that since the trade, the IDXX stock price has decreased by 2.44%, while the SPY has increased by 14.28%. The t

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 01:38
Source
Quiver Quantitative
Ad Hoc News Direct company coverage

IDEXX Laboratories stock holds steady as diagnostics demand supports long-term growth

IDEXX Laboratories, a global leader in veterinary diagnostics and software, demonstrates stable stock performance driven by demand for its services. The company's business model relies on recurring revenue from veterinary clinics and labs, supported by a combination of diagnostic

Tone
Positive 73/100
Event
Earnings
Published
14 Jul 2026 01:18
Source
Ad Hoc News
Quiver Quantitative Direct company coverage

Donald Trump - IDEXX LABS INC Trump Trade on May. 18, 2026

This article details a stock trade made by Donald Trump, specifically a purchase of IDEXX LABS INC (IDXX) shares on May 18, 2026. The transaction amount was between $1,001 and $15,000. Since the trade, IDXX has seen a 3.41% price change, outperforming SPY's 1.74% change over the

Tone
Positive 59/100
Event
Market update
Published
14 Jul 2026 00:38
Source
Quiver Quantitative
marketscreener.com Direct company coverage

Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating

Leerink Partners has revised its price target for IDEXX Laboratories (IDXX) to $715, down from the previous $725. Despite this adjustment, the firm has decided to maintain its 'Outperform' rating on the stock, indicating continued positive sentiment towards the company's performa

Tone
Positive 60/100
Event
Analyst action
Published
13 Jul 2026 13:21
Source
marketscreener.com
Ad-hoc-news.de Direct company coverage

IDEXX Laboratories focuses on diagnostics growth. Investors watch demand trends

IDEXX Laboratories is expanding its veterinary diagnostics franchise by growing its test menu, digital tools, and recurring revenue base. The company benefits from increased pet ownership and diagnostic testing, which drives steady demand for its instruments and consumable test k

Tone
Positive 77/100
Event
Earnings
Published
09 Jul 2026 10:36
Source
Ad-hoc-news.de
MarketWatch Direct company coverage

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) shares dropped 2.56% on Wednesday, closing at $555.67. This underperformance occurred during a generally negative trading session, with the S&P 500 Index and Dow Jones Industrial Average also experiencing declines. The stock's fall ended a four-day

Tone
Negative 39/100
Event
Market update
Published
08 Jul 2026 16:49
Source
MarketWatch
AD HOC NEWS Direct company coverage

IDEXX Laboratories extends its diagnostics reach as a key S&P 500 health-tech name

IDEXX Laboratories is a major S&P 500 player in veterinary diagnostics, actively investing in laboratory services, imaging, and software to enhance pet and livestock health globally. The company's business model relies on recurring revenue from diagnostic testing solutions, consu

Tone
Positive 71/100
Event
Earnings
Published
08 Jul 2026 09:43
Source
AD HOC NEWS
MarketWatch Direct company coverage

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

IDEXX Laboratories Inc. (IDXX) saw its stock advance by 1.29% to $564.98 on Monday, outperforming the broader market. This marked the stock's third consecutive day of gains, occurring on a strong trading session where the S&P 500 Index rose 0.72% and the Dow Jones Industrial Aver

Tone
Positive 73/100
Event
Market update
Published
06 Jul 2026 21:52
Source
MarketWatch
TIKR.com Direct company coverage

IDEXX Laboratories Stock: $876 Target Backed by Cancer Dx Adoption Across 7,500 Practices

IDEXX Laboratories (IDXX) exceeded Q1 2026 revenue and EPS estimates, driven by its Companion Animal Group and increasing adoption of its inVue Dx and Cancer Dx platforms, with the latter now used in 7,500 practices. Despite a slight dip in U.S. clinical visits, diagnostic freque

Tone
Positive 81/100
Event
Earnings
Published
06 Jul 2026 15:53
Source
TIKR.com
AD HOC NEWS Direct company coverage

IDEXX Laboratories stock holds its focus on diagnostics. Investors watch the business mix.

IDEXX Laboratories continues to focus on companion-animal diagnostics, with its business model emphasizing recurring revenue from instruments, reagents, and services for veterinarians and water-testing workflows. The company's U.S. Nasdaq listing and its core identity in animal h

Tone
Positive 67/100
Event
Earnings
Published
06 Jul 2026 10:08
Source
AD HOC NEWS
TradingView Direct company coverage

Price to earnings forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX

The article focuses on the forward price-to-earnings ratio of IDEXX Laboratories, Inc. (NASDAQ: IDXX). It is presented within a financial data platform interface, highlighting the company's stock information and financial metrics without providing specific numerical values in the

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 07:08
Source
TradingView
Stock Titan Direct company coverage

If You Invested $1,000 in IDEXX Laboratories (IDXX)

This article analyzes the historical performance of investing $1,000 in IDEXX Laboratories (IDXX) over different periods, showcasing growth and declines. It details IDXX's business, including its focus on pet healthcare innovation, diagnostic products, software, and telemedicine,

Tone
Positive 67/100
Event
Market update
Published
04 Jul 2026 13:07
Source
Stock Titan
TradingView Direct company coverage

Enterprise value to EBIT forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX

This article focuses on the enterprise value to EBIT forward of IDEXX Laboratories, Inc. (NASDAQ: IDXX). It presents financial data for the company within the TradingView platform, specifically under its section for financial information and market data.

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 10:08
Source
TradingView
Ad-hoc-news.de Direct company coverage

IDEXX Laboratories focuses on diagnostics growth as investors watch long-term demand

IDEXX Laboratories continues to expand its veterinary and water diagnostics, with a business model heavily reliant on recurring revenue from consumables and services. The company benefits from rising pet ownership, increased spending on pet healthcare, and technological advanceme

Tone
Positive 72/100
Event
Earnings
Published
03 Jul 2026 16:27
Source
Ad-hoc-news.de
TradingView Direct company coverage

Price to sales forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX

This article focuses on the "Price to sales forward" metric for IDEXX Laboratories, Inc. (NASDAQ: IDXX) as presented on the TradingView platform. It highlights financial data and market information relevant to the company. The content appears to be a snapshot from a financial dat

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 16:08
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of IDEXX Laboratories, Inc. – LSE:0J8P

This article provides financial information for IDEXX Laboratories, Inc. (LSE:0J8P), specifically its price to earnings forward. It is presented in the context of TradingView's platform, offering an overview of the company's financials for the London Stock Exchange. The content i

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 10:07
Source
TradingView
01net Direct company coverage

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is scheduled to release its 2026 second quarter financial results on Tuesday, August 4, 2026, before market open, followed by an analyst conference call at 8:30 a.m. ET. The company will also host its 2026 Investor Day on Thursday, August 1

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 18:37
Source
01net
Finviz Direct company coverage

IDXX - Idexx Laboratories Inc Volatility & Greeks

This article provides a detailed financial overview of Idexx Laboratories Inc. (IDXX), including its current stock performance, key financial metrics, volatility indicators, and analyst recommendations. It covers various data points from market capitalization to insider transacti

Tone
Neutral 50/100
Event
Analyst action
Published
02 Jul 2026 05:37
Source
Finviz